All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • quaratusugene ozeplasmidREQORSAPhase 22 trials

    Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage

  • QuavonlimabMK-1308Phase 22 trials

    Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer

  • R2R01Phase 22 trials

    River 2 Renal Corp. · Acute Kidney Injury, Hepatorenal Syndrome

  • R3R01Phase 22 trials

    River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis

  • rAAV2tYF-GRK1-RPGRPhase 22 trials

    Beacon Therapeutics · X-Linked Retinitis Pigmentosa

  • RadspherinPhase 22 trials

    Oncoinvent Solutions AS · Peritoneal Carcinomatosis, Ovarian Cancer, Peritoneal Carcinoma

  • RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials

    Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc

  • RBD1016Phase 22 trials

    Ribocure Pharmaceuticals AB · Chronic Hepatitis D, Chronic Hepatitis b

  • RBD5044Phase 22 trials

    Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia

  • RBS2418Phase 22 trials

    Riboscience, LLC. · Metastatic Colorectal Cancer, Advanced Colorectal Cancer, Advanced Unresectable Hepatocellular Carcinoma

  • RC108Phase 22 trials

    RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer

  • RC1416Phase 22 trials

    Nanjing RegeneCore Biotech Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe Asthma

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials

    Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • REGN7544baloncibartPhase 22 trials

    Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension

  • rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials

    BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness

  • rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials

    Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer

  • rivogenlecleucelBPX-501 T cells, BPX-501Phase 22 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • RO7568282Phase 22 trials

    Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease

  • RosnilimabANB030Phase 22 trials

    AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis

  • RSV vaccine candidatePhase 22 trials

    Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization

  • S095029Phase 22 trials

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer

  • SapanisertibFTH-003, MLN0128Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • SAR445877Phase 22 trials

    Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma

  • SAR447537Phase 22 trials

    Sanofi · Alpha 1-Antitrypsin Deficiency, Emphysema

  • SAT-3247Phase 22 trials

    Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy, Duchenne, DMD

  • SCTB39-1Phase 22 trials

    Sinocelltech Ltd. · Advanced Malignant Solid Tumor

  • SCTB39GPhase 22 trials

    Sinocelltech Ltd. · Advanced Malignant Solid Tumor, Advanced Malignant Solid Tumors

  • SelicrelumabPhase 22 trials

    Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma

  • SerabelisibFTH-001, MLN1117Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • SGB-9768Phase 22 trials

    Suzhou Sanegene Bio Inc. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy (IgAN), C3 Glomerulopathy

  • SGC001Phase 22 trials

    Beijing Sungen Biomedical Technology Co., Ltd · Acute Anterior ST-Segment Elevation Myocardial Infarction, Acute Pancreatitis

  • Shigella4V2Phase 22 trials

    LimmaTech Biologics AG · Shigellosis

  • SHJ002Phase 22 trials

    Sunhawk Vision Biotech, Inc. · Myopia, Progressive, Corneal Erosion

  • SHR-4375Phase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumor, Solid Tumors

  • SHR-4849Phase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors

  • SHR0302BasePhase 22 trials

    Jiangsu HengRui Medicine Co., Ltd. · Vitiligo, Non-segmental Vitiligo

  • silevertinibBDTX-1535Phase 22 trials

    Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM

  • SKB103Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors, Breast Cancer

  • SKB500Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer

  • SKB518Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Gynecological Malignancies, Lung Carcinoma

  • SL-325Phase 22 trials

    Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)

  • SLN12140Phase 22 trials

    Linno Pharmaceuticals, Inc. · IgA Nephropathy (IgAN), Paroxysmal Nocturnal Hemoglobinuria (PNH)

  • SNK01Phase 22 trials

    NKGen Biotech, Inc. · Alzheimer Disease, Moderate Alzheimer Disease

  • SolrikitugPhase 22 trials

    Uniquity One (UNI) · Eosinophilic Esophagitis (EoE), COPD

  • SPGL008Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer

  • SPT-300LYT-300, GlyphAlloPhase 22 trials

    Seaport Therapeutics · Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress

  • SPY001SPY001-001Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

NewerPage 39 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.